Loading clinical trials...
Loading clinical trials...
Standard of Care Versus a New Collagen and Polyethylene Glycol Haemostatic/Sealant Patch (Hemopatch) During Liver Resection. A Multicentre, Non-inferiority Prospective Randomized Study (IBERLIVER-study)
Conditions
Interventions
Hemopatch
Standard of care
Start Date
December 1, 2017
Primary Completion Date
April 1, 2020
Completion Date
September 1, 2020
Last Updated
November 9, 2017
NCT06345508
NCT07447050
NCT06440005
NCT06447064
NCT05727787
NCT07295262
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions